This provider's $28.6M in total Medicare payments ranks in the 97th percentile of Clinical Laboratory providers nationally.
Medicare payments to this provider grew 2938% from 2016 to 2023.
AI-generated analysis based on Medicare payment data.
Notable: Payments increased 434% in 2017
Year-over-year payment surges can indicate changes in practice volume, new services, or billing pattern shifts.
Average per-service amounts submitted by the provider compared to what Medicare actually paid — the gap represents the markup.
| Year | Avg Submitted | Avg Paid | Markup Ratio | Gap per Service | Total Payments | Services | Beneficiaries |
|---|---|---|---|---|---|---|---|
| 2016 | $281.41 | $57.94 | 4.86x | $223.47 | $205.2K | 3.5K | 15 |
| 2017 | $431.88 | $184.83 | 2.34x | $247.05 | $1.1M | 5.9K | 4 |
| 2018 | $417.87 | $172.13 | 2.43x | $245.74 | $3.1M | 18.2K | 5 |
| 2019 | $282.13 | $112.01 | 2.52x | $170.12 | $3.5M | 31.0K | 33 |
| 2020 | $124.47 | $44.72 | 2.78x | $79.75 | $2.8M | 62.1K | 45 |
| 2021 | $85.54 | $37.76 | 2.27x | $47.78 | $5.2M | 138.6K | 61 |
| 2022 | $86.53 | $39.77 | 2.18x | $46.76 | $6.4M | 160.8K | 52 |
| 2023 | $77.30 | $34.37 | 2.25x | $42.93 | $6.2M | 181.4K | 55 |
| Code | Description | Services | Payments | Avg/Service | Markup |
|---|---|---|---|---|---|
| G0483 | Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms | 32.6K | $7.9M | $242.49 | 2.53x |
| 87798 | Detection test by nucleic acid for organism, amplified probe technique | 135.5K | $4.7M | $34.66 | 1.77x |
| G0481 | Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms | 20.6K | $3.2M | $155.84 | 2.57x |
| 80307 | Testing for presence of drug, by chemistry analyzers | 38.5K | $2.5M | $64.51 | 2.33x |
| 87150 | Identification of organisms by genetic analysis, amplified probe technique | 54.9K | $1.9M | $34.71 | 1.77x |
| G0482 | Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms | 8.7K | $1.7M | $195.58 | 2.56x |
| 87481 | Detection test for candida species (yeast), amplified probe technique | 26.9K | $933.7K | $34.65 | 1.77x |
| 87653 | Detection test by nucleic acid for strep (streptococcus, group b), amplified probe technique | 13.4K | $466.0K | $34.65 | 1.77x |
| 87641 | Detection test by nucleic acid for staphylococcus aureus, methicillin resistant (mrsa bacteria), amplified probe technique | 12.7K | $439.3K | $34.67 | 1.77x |
| 87640 | Detection test by nucleic acid for staphylococcus aureus (bacteria), amplified probe technique | 12.5K | $433.7K | $34.64 | 1.77x |
| 87631 | Detection test by nucleic acid for multiple types of respiratory virus, multiple types or subtypes, 3-5 targets | 2.1K | $300.8K | $140.06 | 1.78x |
| 82306 | Vitamin d-3 level | 7.9K | $234.8K | $29.59 | 3.20x |
| U0003 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r | 3.1K | $227.8K | $73.65 | 1.70x |
| 82670 | Measurement of total estradiol (hormone) | 7.2K | $199.3K | $27.83 | 3.23x |
| 84403 | Testosterone (hormone) level, total | 7.1K | $183.5K | $25.71 | 3.31x |
| 82627 | Dehydroepiandrosterone (dhea-s) hormone level | 7.1K | $157.8K | $22.15 | 3.39x |
| 84270 | Sex hormone binding globulin (protein) level | 7.2K | $155.2K | $21.66 | 3.46x |
| 84443 | Blood test, thyroid stimulating hormone (tsh) | 9.1K | $153.1K | $16.87 | 3.56x |
| 84144 | Progesterone (reproductive hormone) level | 6.8K | $142.2K | $20.79 | 3.46x |
| 83001 | Gonadotropin, follicle stimulating (reproductive hormone) level | 6.6K | $122.0K | $18.51 | 3.24x |
This provider submits charges 2.36 times higher than what Medicare actually pays.
A markup ratio of 2.36x means for every $100 Medicare pays, this provider initially charges $236. This is higher than the national average.
Always verify provider credentials and location before scheduling appointments. This data reflects Medicare payments and may not include all practice locations.
Other Clinical Laboratory providers in CA for peer comparison.
| Provider | Location | Total Payments | Status |
|---|---|---|---|
| Genomic Health, Inc. | Redwood City, CA | $887.6M | ✓ Clear |
| Unilab Corporation | West Hills, CA | $868.8M | ⚠️ Flagged |
| Caredx Inc. | Brisbane, CA | $751.0M | ✓ Clear |
| Laboratory Corporation Of America | San Diego, CA | $592.4M | ⚠️ Flagged |
| Millennium Health, Llc | San Diego, CA | $587.9M | ✓ Clear |
Share this provider's Medicare payment information
Last Updated: February 2026 (data through 2023, the latest CMS release)
Note: All data is from publicly available Medicare records. OpenMedicare is an independent journalism project not affiliated with CMS.
Believe this data is inaccurate? Dispute this data